145 related articles for article (PubMed ID: 17902051)
21. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
22. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
Hussein-Fikret S; Fuller PJ
Mol Cell Endocrinol; 2005 Jan; 229(1-2):149-60. PubMed ID: 15607539
[TBL] [Abstract][Full Text] [Related]
23. Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status.
Martinez de Arrieta C; Koibuchi N; Chin WW
Endocrinology; 2000 May; 141(5):1693-8. PubMed ID: 10803578
[TBL] [Abstract][Full Text] [Related]
24. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells.
Sarvilinna N; Eronen H; Miettinen S; Vienonen A; Ylikomi T
Int J Cancer; 2006 Feb; 118(4):832-40. PubMed ID: 16152593
[TBL] [Abstract][Full Text] [Related]
25. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.
Wagner M; Koslowski M; Paret C; Schmidt M; Türeci O; Sahin U
BMC Cancer; 2013 Dec; 13():570. PubMed ID: 24304549
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.
Jaber BM; Mukopadhyay R; Smith CL
J Mol Endocrinol; 2004 Feb; 32(1):307-23. PubMed ID: 14766010
[TBL] [Abstract][Full Text] [Related]
27. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
[TBL] [Abstract][Full Text] [Related]
28. p300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression independently of its histone acetyltransferase activity.
Gao B; Xu W; Zhong L; Zhang Q; Su Y; Xiong S
Eur J Immunol; 2013 Aug; 43(8):2174-84. PubMed ID: 23670564
[TBL] [Abstract][Full Text] [Related]
29. Expression and hormonal regulation of coactivator and corepressor genes.
Misiti S; Schomburg L; Yen PM; Chin WW
Endocrinology; 1998 May; 139(5):2493-500. PubMed ID: 9564863
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.
Shao F; Guo T; Chua PJ; Tang L; Thike AA; Tan PH; Bay BH; Baeg GH
Histopathology; 2015 Nov; 67(5):709-18. PubMed ID: 25817822
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional activation by estrogen receptor (ERalpha) and steroid receptor coactivator (SRC1) involves distinct mechanisms in yeast and mammalian cells.
Sheppard HM; Matsuda S; Harries JC; Kindle KB; Heery DM
J Mol Endocrinol; 2003 Jun; 30(3):411-22. PubMed ID: 12790809
[TBL] [Abstract][Full Text] [Related]
32. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.
Zhao C; Yasui K; Lee CJ; Kurioka H; Hosokawa Y; Oka T; Inazawa J
Cancer; 2003 Jul; 98(1):18-23. PubMed ID: 12833450
[TBL] [Abstract][Full Text] [Related]
34. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance of SIRT1 and p300/CBP expression in gastroesophageal junction (GEJ) cancer and the correlation with E-cadherin and MLH1.
Zhang LH; Huang Q; Fan XS; Wu HY; Yang J; Feng AN
Pathol Res Pract; 2013 Oct; 209(10):611-7. PubMed ID: 24035280
[TBL] [Abstract][Full Text] [Related]
36. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR
Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer.
Bauer M; Eickhoff JC; Gould MN; Mundhenke C; Maass N; Friedl A
Breast Cancer Res Treat; 2008 Apr; 108(3):389-97. PubMed ID: 17554627
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
[TBL] [Abstract][Full Text] [Related]
39. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V
Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.
Paulsson J; Sjöblom T; Micke P; Pontén F; Landberg G; Heldin CH; Bergh J; Brennan DJ; Jirström K; Ostman A
Am J Pathol; 2009 Jul; 175(1):334-41. PubMed ID: 19498003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
